COMPARISON TOOL

Compare peptides

Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.

Mazdutide

Max 4 peptides

Property	Mazdutide
Category	GLP-1
Type	Peptide
Mechanism	Dual GLP-1 / glucagon receptor agonist
Status	Phase 3
Dosing range	3–9 mg weekly
Frequency	Once weekly
Half-life	~7 days (limited data)
Route	Subcutaneous
Onset	2–4 weeks for appetite reduction
Studied for	Weight management Liver fat reduction Type 2 diabetes
Key risks	Nausea Vomiting Diarrhea Constipation Heart-rate increase
Storage	Refrigerated (2–8 °C); use within the pharmacy beyond-use date
Available at G1	Not currently carried. Ask a provider
Tools	Dosage calculator →

PROPERTY COMPARISON · RADAR

Editorial profile scores (0–10) for orientation — not clinical measurements.

TYPICAL DOSE RANGES

Mazdutide3 mg – 9 mg

Typical per-dose range on a logarithmic scale. Your provider sets your dose.

For educational purposes only. Consult a licensed provider before starting any peptide protocol.